Apocynum venetum L. (Luobuma in Chinese, Apocynaceae) is a wild shrub widely distributed in mid and northwestern China. Since ancient times the leaves of A. venetum have been used in traditional Chinese medicine for the treatment of hypertension, nephritis and neurasthenia. 1) Previous papers describe the diuretic, 2) antihyperlipemic 3) and sedative effects 4) of the plant. The leaves of A. venetum are also used in China as an anti-aging agent. 1) This effect might be related to the relatively high amount of flavonoids. A recent paper demonstrated that hyperoside in Apocynum leaves had a strong inhibitory effect in a lipid-peroxidation assay. 5) Flavonoids are polyphenolic compounds that are ubiquitously present in foods of plant origin. Flavonoids are capable of modulating the activity of enzymes and affect the behaviour of many cell systems, suggesting that the compounds may possess significant antihepatotoxic, antiallergic, anti-inflammatory, antiosteoporotic and even antitumour activities. 6, 7) Interestingly, the list of plant flavonoids did not include effects on the central nervous system (CNS) up to 1990 when Paladini et al. described the anxiolytic potency of chrysin (5,7-dihydroxyflavone) and apigenin (5,7,4Ј-trihydroxyflavone). 8) Since then, a great deal of research has been done in this field. Recently, it was shown that a flavonoid fraction obtained from a crude extract of Hypericum perforatum (St. John's wort) was remarkably active in a forced swimming test (FST). 9) Isolates obtained from this fraction including hyperoside, isoquercitrin, miquelianin and quercitrin were also active in the FST. These data gave the first evidence that some natural flavonoids possess antidepressant activity.
In the present study it was therefore of interest to investigate the effects of an extract of A. venetum leaves (Apocynum extract), containing an amount of 2.1% hyperoside and 2.7% isoquercitrin, in the FST. The FST was chosen as this test is a valid animal model to detect antidepressant compounds. 10) 
MATERIALS AND METHODS

Animals
Male CD rats (230-250 g, Charles River WIGA, Sulzfeld, Germany) were used. The animals were kept in a 12 h light/dark cycle at a constant temperature of 25Ϯ1°C with free access to food (altromin 1324) and tap water. Animals were divided randomly into control and experimental groups. Animal experiments were officially approved by the Regierungspräsident, Münster (A 38/93).
Preparation of Apocynum Extract Leaves of Apocynum venetum (100 g) was refluxed for 1 h in aqueous ethanol (70% v/v, 60 ml) twice and the combined alcoholic extract was evaporated to dryness (28 g). The extract (13.5 g) was dissolved in hot water (200 ml), and adjusted to pH 3.0 with sulfuric acid, then filtered. The filtrate was chromatographed on DIAION HP-20 (3.6 cm i.d.ϫ18 cm) and eluted with water (200 ml) and then aquous ethanol (70% v/v, 200 ml). The aqueous ethanol fraction was collected and evaporated to dryness to obtain Apocynum extract (4.2 g).
The extract contained 2.1% hyperoside and 2.7% isoquercitrin, respectively. HPLC analytical conditions were as follows: Column: SHISEIDO CAPCELL PAKC18 (UG) 4.6 mm i.d.ϫ150 mm, detector at 330 nm, mobile phase: 0.1% TFA in water/0.1%TFA in acetonitrile 85 : 15, flow rate: 1.0 ml/min. Equipment: Waters 600 with a Waters 2487 UV detector. Hyperoside appeared at 13.5 min and isoquercitrin at 14.7 min. Authentic hyperoside and isoquercitrin were purchased from Funakoshi (Tokyo, Japan).
Drug Treatment Imipramine-HCL was purchased from Sigma (Deisenhofen) and dissolved in deionized water. For all experiments, powdered Apocynum extract (drug/extract ratio: 25/2 prepared by Tokiwa Phytochemical Co., Ltd., Chiba, Japan) was used. Apocynum extract was dissolved homogeneously in water by sonication. Control animals received deionized water only. All substances were administered orally by gavage.
FST after Acute Pre-treatment The purpose of this experiment was to investigate whether an Apocynum extract possesses antidepressant activity in the FST. The administered dose range of the extract was chosen in the same manner as that of St. John's wort extract 9) since Apocynum extract contains an almost equal amount of flavonoids to those of St. John's wort extract. Subsequently, a group of 40 animals was subdivided as follows: 8 animals were treated with imipramine A dosage of 30 mg/kg imipramine was chosen for the acute study because former experiments indicated that dosages below 30 mg were only partially active; for chronic treatment 20 mg/kg proved to be an active dosage without any toxic effects, whereas higher doses of imipramine showed toxic effects in the chronic treatment (Butterweck, unpublished results).
Measurement of Immobility This experiment was performed using the FST according to the method published by Porsolt et al. 12) Male rats were placed in a plexiglass cylinder (40ϫ18 cm i.d.) containing a column of 17 cm of water at 25Ϯ1°C. According to Porsolt the rats learned in a pretest session of 15 min that they could not escape from the cylinder. In the test period, 24 h later, the animals were exposed to the experimental conditions for 5 min. A rat was judged to be immobile whenever it remained floating in the water, in an upright position, making only small movements to keep its head above the water.
The FST for both treatment paradigms was performed between 1-3 p.m. and recorded by a video camera. The tapes were evaluated by an observer who was not informed about the kind of treatment each animal had received.
Measurement of Locomotor Activity In order to see whether changes in immobility were associated with changes in motor activity as described by Porsolt et al. 11) for amphetamine and caffeine, animals treated with the various substances were tested for activity in an open field. For measurement of locomotor activity naive rats were placed in an open field apparatus. The open field apparatus was an arena 70 cm in diameter divided into 18 approximately equal areas. Handoperated counters were employed to score locomotion (number of line crossings within 5 min) and rearing frequencies (number of times an animal stood on its hind legs). In this experiment the animals received the same drugs and doses as used for the measurement of immobility after repeated treatment. For open field observations, each rat was individually placed in the center of the arena 15 h after the last treatment and its behavioural parameters were recorded for 5 min. The open field apparatus was washed with a detergent solution before each behavioural test to eliminate possible odor clues left by previous subjects. To minimize circadian changes in the rat open-field behaviour, control and experimental animals were intermixed. Open field observations were made between 8-9 a.m.
Statistics All data were expressed as the meanϮS.E.M. Group mean differences were ascertained with analysis of variance (ANOVA). Multiple comparisons among treatment means were checked with the Fisher-PLSD. The results were considered significant if the probability of error was Ͻ5%.
RESULTS
As shown in Fig. 1 , immobility was significantly reduced after acute pre-treatment by imipramine (30 mg/kg) and Apocynum extract (125 mg/kg). No effects after acute administration were observed in the FST for the higher doses of the extract (250, 500 mg/kg). However, 14 d after daily pre-treatment, the extract markedly reduced immobility at a dosage of 30 and 125 mg/kg (Fig. 2) . This effect was comparable to that of the tricyclic antidepressant imipramine (20 mg/kg), although the effect of the synthetic substance was more pronounced. The dosage of 60 mg/kg of the extract slightly reduced immobility, but the effect was not significant. Neither imipramine (20 mg/kg) nor the Apocynum extract in various doses (30, 60, 125 mg/kg) produced any overt behavioural change or motor dysfunction in the open field test (Table 1) . In fact, none of the drugs increased open field activity. 
DISCUSSION
Our present experiments show for the first time that an extract of the leaves of A. venetum L. possesses antidepressant activity in the FST, a valid animal model for screening antidepressant drugs. 10) A major problem in the search for new antidepressant drugs is the question which animal model is most appropriate to identify diverse antidepressant treatments correctly, without making errors of omission or commission and whether antidepressant effects are only present on, or still exist after chronic administration. 10) One model which attempts to meet those requirements is the FST developed by Porsolt et al.
12) The authors described procedures for producing a state resembling depression in rats. The test is based on the observation that rats when forced to swim in a restricted space from which they cannot escape will cease apparent attempts to escape and become immobile exhibiting only small movements necessary to keep their heads above the water.
11) The authors suggested that this characteristic immobile posture reflects a state of despair in the rat; it is assumed that the animals have "given up hope of escaping." Immobility is reduced by a variety of agents which are therapeutically active in depression 11) including tricyclics, monoamine-oxidase-inhibitors (MAO's) and newer antidepressants but not clearly 5-HT uptake inhibitors. 13) There is, in fact, a significant correlation between clinical potency and potency of antidepressants in the FST 14) ; this was not found in any other model. The specificity of this test for antidepressants has been questioned as a large number of non-antidepressants also reduce immobility. False positive results have been reported for stimulants, anticholinergics, antihistaminics, pentobarbital and opiates. [14] [15] [16] [17] [18] It has been found that whereas response to antidepressants continues by chronic treatment, the response to antihistaminics disappeared on chronic administration. 19) The effects of psychostimulants such as caffeine or amphetamine can be excluded by additional open field tests which would markedly increase locomotor activity.
11)
However, in our present study an Apocynum extract significantly reduced immobility time in the FST after acute administration at a dosage of 125 mg/kg, an effect which was comparable to that of the synthetic antidepressant imipramine at a dosage of 30 mg/kg. Higher doses of the Apocynum extract (250, 500 mg/kg) remained inactive after acute pretreatment. To exclude false positive results which might be due to effects of antihistaminics, an additional FST was performed after 14 d of daily treatment. After repeated treatment, Apocynum extract markedly shortened the immobility time in the FST at a dose range of 30-125 mg/kg, although the effect may not be in a dose-dependent fashion, similar to that of St. John's wort extract.
9) These could be preliminary data which gave the first hints of possible antidepressant activity of Apocynum extract and further dose range tests might be needed. The effect of the extract in the FST after a pre-treatment period of 14 d was comparable to that of the tricyclic antidepressant imipramine (20 mg/kg), although the effect of the synthetic substance was more pronounced after repeated treatment. Neither imipramine (20 mg/kg) nor the Apocynum extract at various doses (30, 60, 125 mg/kg) produced any overt behavioural change or motor dysfunction in the open field test, so that the observed effects in the FST were not due to a stimulation of locomotor activity. The results of the FST after repeated treatment and after additional open field tests confirms the assumption that the antidepressant effect of an Apocynum extract in the FST is specific. Further, it can be speculated that this effect might be related to hyperoside and isoquercitrin, as both flavonoids recently showed antidepressant actvity in the FST. 9) A further reason for this assumption is that the effective extract doses used in the present study correlate well with the effective hyperoside and isoquercitrin doses applied in the previous study by Butterweck et al. 9) In detail, Butterweck et al. showed that pure hyperoside significantly shortened immobility time in the FST in a dose range of 0.6-1.3 mg/kg, whereas the effects of doses below 0.6 mg/kg and above 1.3 mg/kg were not significantly different from control in St. John's wort extract. 9) Pure isoquercitrin was also active in the FST at a dosage of 0.6 mg/kg. 9) This amount of hyperoside as well as of isoquercitrin is approximately reached with 30 mg/kg of the Apocynum extract, which was active in the FST after repeated treatment. The fact that 125 mg/kg of the Apocynum extract was also active in the FST after acute and repeated treatment leads to the assumption that this extract probably contains other substances with possible antidepressant potential. Further investigations in this direction are necessary to confirm this hypothesis. The behavioural parameters were recorded for 5 min. Locomotion; number of line crossings within 5 min. Rearing; number of times an animal stood on its hind legs.
Values are expressed as meanϮS.E.
